For many clinicians practicing integrative medicine, IgG food sensitivity testing (performed by companies like Genova Diagnostics) occupies an interesting and often uncomfortable space. On one hand, professional allergy societies have recommended against its use for more than 15 years. On the other hand, many functional and integrative physicians report seeing meaningful clinical improvements when IgG testing is used to guide food elimination trials in selected patients.
The tension between these perspectives raises an important question: has the evidence evolved enough since the landmark 2008 European Academy of Allergy and Clinical Immunology (EAACI) Task Force Report to justify a second look?
The 2008 paper by Stapel and colleagues remains one of the most frequently cited position statements against food-specific IgG4 testing. The authors argued that food-specific IgG4 antibodies primarily represent exposure and immunologic tolerance rather than pathology. They noted that healthy individuals commonly demonstrate elevated IgG4 antibodies to foods they consume regularly and that there was little evidence supporting an effector role for IgG4 in food hypersensitivity. Their conclusion was unequivocal: food-specific IgG4 testing should not be used in the diagnostic workup of food allergy or food intolerance.¹
At the time, this conclusion was reasonable. The available literature largely consisted of studies demonstrating that food-specific IgG4 antibodies were common in asymptomatic individuals. In fact, the task force emphasized that elevated IgG4 responses may reflect the opposite of disease—a state of successful immune tolerance mediated by regulatory T cells and IL-10 signaling.¹ The concern was that broad food sensitivity panels could lead to unnecessary dietary restriction, overdiagnosis, and patient confusion.
Importantly, however, the 2008 report focused primarily on classical food allergy and food intolerance. It was written before eosinophilic esophagitis (EoE) had emerged as a major area of investigation and before researchers began exploring whether food-specific IgG4 might play a role in a distinct, non-IgE-mediated inflammatory disease process.
Over the last decade, EoE has transformed our understanding of food-triggered immune responses. While EoE has traditionally been considered an allergic disease, conventional allergy testing has often performed poorly in identifying clinically relevant trigger foods. Six-food elimination diets frequently produce histologic remission, yet skin-prick testing and serum IgE testing have generally shown disappointing predictive value.
Against this backdrop, investigators have begun exploring whether food-specific IgG4 may function not as a marker of classic food allergy, but as a biomarker of food antigen exposure driving eosinophilic inflammation.
A particularly intriguing study was published in 2024 by Lim and colleagues. In this prospective controlled study, investigators measured serum food-specific IgG4 levels in adults with active EoE and compared them with controls. They found significantly elevated IgG4 levels against several common EoE trigger foods—including milk, wheat, soy, egg, and nuts—in patients with active disease. More importantly, they used these results to guide targeted elimination diets.²
The findings were notable. After six weeks of eliminating foods identified by elevated IgG4 levels, 45% of patients achieved histologic remission, defined as fewer than 15 eosinophils per high-power field. Patients also experienced statistically significant improvements in dysphagia symptom scores and endoscopic findings.² Although the remission rate was not dramatically higher than what has been reported with empiric elimination diets, the authors argued that a targeted approach may reduce dietary burden by eliminating a median of only two food groups rather than the six foods commonly removed in traditional protocols.
Perhaps most interestingly, the study found that food-specific IgG4 appeared to outperform food-specific IgE in distinguishing patients with EoE from controls. Receiver operating characteristic analysis demonstrated stronger diagnostic characteristics for IgG4 than IgE, and the combination of IgG4 with peripheral eosinophil counts further improved predictive performance.²
To be clear, this study does not overturn the conclusions of the 2008 EAACI position paper. The sample size was small, consisting of only 22 patients with active EoE. The elimination period was relatively short, there was no randomized comparison against empiric elimination diets, and the observed histologic remission rate leaves substantial room for improvement. The study also cannot establish whether IgG4 is causally involved in disease pathogenesis or merely serves as a marker of exposure to foods driving inflammation through other mechanisms.
Nevertheless, it does suggest that the conversation surrounding food-specific IgG4 may be more nuanced than it appeared in 2008.
One could argue that both perspectives may be simultaneously correct. Stapel and colleagues were likely correct that elevated food-specific IgG4 does not diagnose food allergy and should not be interpreted as evidence that a food is inherently harmful. Yet newer EoE research raises the possibility that in specific disease states, patterns of food-specific IgG4 may contain clinically useful information capable of guiding therapeutic elimination diets.
This distinction is important. The question is no longer simply whether IgG4 represents tolerance or pathology. Rather, the emerging question is whether IgG4 can serve as a clinically useful biomarker in selected conditions characterized by chronic antigen-driven inflammation.
This possibility may partially explain the persistent anecdotal reports from many integrative and functional medicine physicians who have used IgG testing for years. Although these observations do not substitute for controlled trials, many clinicians report that IgG-guided elimination diets occasionally identify foods that, when removed and later reintroduced, appear to influence symptoms ranging from gastrointestinal complaints to headaches, eczema, and chronic inflammatory conditions. Whether these effects are mediated through mechanisms involving IgG4 itself remains uncertain, but the clinical experiences have been difficult to dismiss entirely.
The EoE literature does not validate broad claims about IgG food sensitivity testing. However, it does remind us that biomarkers initially dismissed as clinically irrelevant may warrant reexamination when viewed through the lens of evolving immunology. As our understanding of non-IgE-mediated food-related diseases expands, the role of food-specific IgG4 may ultimately prove more complex than either its strongest proponents or its strongest critics originally envisioned.
References
- Stapel SO, Asero R, Ballmer-Weber BK, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. 2008;63(7):793-796.
- Lim AHW, Ngoi B, Perkins GB, et al. Outcomes of serum food-specific immunoglobulin G4 to guide elimination diet in patients with eosinophilic esophagitis. Am J Gastroenterol. 2024;119(6):1066-1073.